• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-335在甲状腺乳头状癌中表达下调,并通过直接靶向锌指E盒结合蛋白2抑制癌细胞的生长、迁移和侵袭。

MicroRNA-335 is downregulated in papillary thyroid cancer and suppresses cancer cell growth, migration and invasion by directly targeting ZEB2.

作者信息

Kan Quan'e, Su Yong, Yang Huihui

机构信息

Department of Endocrinology, Henan Provincial People's Hospital, Zhengzhou, Henan 450003, P.R. China.

出版信息

Oncol Lett. 2017 Dec;14(6):7622-7628. doi: 10.3892/ol.2017.7126. Epub 2017 Oct 3.

DOI:10.3892/ol.2017.7126
PMID:29344210
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5755184/
Abstract

MicroRNAs (miRs) are a group of short, endogenous, non-protein-coding and single-stranded RNAs that regulate gene expression by binding to the 3'-untranslated region (3'UTR) of mRNAs, which results in their degradation or translational repression. The aim of the present study was to investigate the expression and function of miR-335 in human papillary thyroid cancer (PTC). Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was performed to quantify the relative miR-335 expression levels in PTC tissues and cell lines. The effect of miR-335 on the proliferation, migration and invasion of PTC cells was assessed by an MTT assay, and transwell migration and invasion assays, respectively. Dual-luciferase reporter assays were employed to explore whether miR-335 directly targeted the 3'UTR of the potential target gene zinc finger E-box binding homeobox 2 (ZEB2). RT-qPCR and western blotting were adopted to assess the effect of miR-335 on the mRNA and protein expression of ZEB2. RT-qPCR revealed that miR-335 was downregulated in PTC tissues and cell lines. The MTT assay and transwell migration and invasion assays demonstrated that the overexpression of miR-335 significantly inhibited the proliferation, migration and invasion of PTC cells. ZEB2 was identified as a direct target of miR-335 with computational analysis, which was confirmed with a dual-luciferase reporter assay, RT-qPCR and western blotting. The knockdown of ZEB2 significantly inhibited the proliferation, migration and invasion of PTC cells, indicating that ZEB2 may be a functional target of miR-335. Taken together, these findings suggested that miR-335 functioned as a tumor suppressor and suppressed the growth and metastatic behavior of PTC cells by targeting ZEB2.

摘要

微小RNA(miR)是一组短的、内源性的、非蛋白质编码的单链RNA,它们通过与mRNA的3'-非翻译区(3'UTR)结合来调节基因表达,从而导致mRNA降解或翻译抑制。本研究的目的是探讨miR-335在人甲状腺乳头状癌(PTC)中的表达及功能。采用逆转录-定量聚合酶链反应(RT-qPCR)来定量PTC组织和细胞系中miR-335的相对表达水平。分别通过MTT法、Transwell迁移和侵袭实验评估miR-335对PTC细胞增殖、迁移和侵袭的影响。采用双荧光素酶报告基因实验来探究miR-335是否直接靶向潜在靶基因锌指E盒结合同源框2(ZEB2)的3'UTR。采用RT-qPCR和蛋白质印迹法评估miR-335对ZEB2 mRNA和蛋白质表达的影响。RT-qPCR结果显示,miR-335在PTC组织和细胞系中表达下调。MTT法、Transwell迁移和侵袭实验表明,miR-335过表达显著抑制PTC细胞的增殖、迁移和侵袭。通过计算分析确定ZEB2是miR-335的直接靶标,双荧光素酶报告基因实验、RT-qPCR和蛋白质印迹法证实了这一点。敲低ZEB2显著抑制PTC细胞的增殖、迁移和侵袭,表明ZEB2可能是miR-335的功能靶标。综上所述,这些发现提示miR-335作为一种肿瘤抑制因子,通过靶向ZEB2抑制PTC细胞的生长和转移行为。

相似文献

1
MicroRNA-335 is downregulated in papillary thyroid cancer and suppresses cancer cell growth, migration and invasion by directly targeting ZEB2.微小RNA-335在甲状腺乳头状癌中表达下调,并通过直接靶向锌指E盒结合蛋白2抑制癌细胞的生长、迁移和侵袭。
Oncol Lett. 2017 Dec;14(6):7622-7628. doi: 10.3892/ol.2017.7126. Epub 2017 Oct 3.
2
miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4.微小RNA-183通过靶向程序性细胞死亡蛋白4来调节甲状腺乳头状癌的生物学行为。
Oncol Rep. 2015 Jul;34(1):211-20. doi: 10.3892/or.2015.3971. Epub 2015 May 11.
3
MicroRNA-545 targets ZEB2 to inhibit the development of non-small cell lung cancer by inactivating Wnt/β-catenin pathway.微小RNA-545通过使Wnt/β-连环蛋白信号通路失活,靶向锌指E盒结合蛋白2以抑制非小细胞肺癌的发展。
Oncol Lett. 2019 Sep;18(3):2931-2938. doi: 10.3892/ol.2019.10619. Epub 2019 Jul 15.
4
MicroRNA-30a suppresses papillary thyroid cancer cell proliferation, migration and invasion by directly targeting E2F7.微小RNA-30a通过直接靶向E2F7抑制甲状腺乳头状癌细胞的增殖、迁移和侵袭。
Exp Ther Med. 2019 Jul;18(1):209-215. doi: 10.3892/etm.2019.7532. Epub 2019 Apr 30.
5
MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2.miR-577 通过靶向 SphK2 抑制甲状腺乳头状癌细胞的增殖、迁移和侵袭。
Eur Rev Med Pharmacol Sci. 2017 Oct;21(17):3794-3800.
6
UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.UBE2C 被 miR-548e-5p 直接靶向,增加了与非小细胞肺癌中 EMT 标志物蛋白锌指 E-box 结合同源框 1/2 相互作用的癌细胞的细胞生长和侵袭能力。
Theranostics. 2019 Mar 17;9(7):2036-2055. doi: 10.7150/thno.32738. eCollection 2019.
7
MiR-296-5p suppresses papillary thyroid carcinoma cell growth via targeting PLK1.miR-296-5p 通过靶向 PLK1 抑制甲状腺乳头状癌细胞生长。
Eur Rev Med Pharmacol Sci. 2019 Mar;23(5):2084-2091. doi: 10.26355/eurrev_201903_17251.
8
miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer.微小RNA-124基于锌指E盒结合同源盒蛋白2靶点调控上皮-间质转化,以抑制三阴性乳腺癌的侵袭和转移。
Pathol Res Pract. 2019 Apr;215(4):697-704. doi: 10.1016/j.prp.2018.12.039. Epub 2018 Dec 31.
9
miR-873-5p Inhibits Cell Migration and Invasion of Papillary Thyroid Cancer via Regulation of CXCL16.miR-873-5p通过调控CXCL16抑制甲状腺乳头状癌的细胞迁移和侵袭。
Onco Targets Ther. 2020 Feb 4;13:1037-1046. doi: 10.2147/OTT.S213168. eCollection 2020.
10
CircMMP11 regulates proliferation, migration, invasion, and apoptosis of breast cancer cells through miR-625-5p/ZEB2 axis.环状MMP11通过miR-625-5p/ZEB2轴调节乳腺癌细胞的增殖、迁移、侵袭和凋亡。
Cancer Cell Int. 2021 Feb 25;21(1):133. doi: 10.1186/s12935-021-01816-z.

引用本文的文献

1
MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer.微小RNA作为甲状腺癌中细胞迁移和侵袭的关键调节因子。
Biomark Res. 2022 Jun 4;10(1):40. doi: 10.1186/s40364-022-00382-4.
2
MicroRNAs in Papillary Thyroid Cancer: What Is New in Diagnosis and Treatment.甲状腺乳头状癌中的微小RNA:诊断与治疗的新进展
Front Oncol. 2022 Feb 3;11:755097. doi: 10.3389/fonc.2021.755097. eCollection 2021.
3
An 8 miRNA-Based Risk Score System for Predicting the Prognosis of Patients With Papillary Thyroid Cancer.一个基于 8 个 miRNA 的风险评分系统,用于预测甲状腺乳头状癌患者的预后。
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820965594. doi: 10.1177/1533033820965594.
4
MicroRNAs and Their Influence on the ZEB Family: Mechanistic Aspects and Therapeutic Applications in Cancer Therapy.微小 RNA 及其对 ZEB 家族的影响:在癌症治疗中的机制方面和治疗应用。
Biomolecules. 2020 Jul 12;10(7):1040. doi: 10.3390/biom10071040.
5
miR-335 modulates Numb alternative splicing via targeting RBM10 in endometrial cancer.miR-335 通过靶向子宫内膜癌细胞中的 RBM10 调节 Numb 可变剪接。
Kaohsiung J Med Sci. 2020 Mar;36(3):171-177. doi: 10.1002/kjm2.12149. Epub 2020 Jan 2.
6
Emerging roles of the long non-coding RNA 01296/microRNA-143-3p/MSI2 axis in development of thyroid cancer.长链非编码 RNA 01296/微小 RNA-143-3p/MSI2 轴在甲状腺癌发展中的新兴作用。
Biosci Rep. 2019 Nov 29;39(11). doi: 10.1042/BSR20182376.
7
Low microRNA-622 expression predicts poor prognosis and is associated with ZEB2 in glioma.微小RNA-622低表达预示着胶质瘤预后不良且与锌指E盒结合蛋白2相关。
Onco Targets Ther. 2019 Sep 10;12:7387-7397. doi: 10.2147/OTT.S218161. eCollection 2019.
8
MicroRNA‑30a regulates cell proliferation, migration, invasion and apoptosis in human nasopharyngeal carcinoma via targeted regulation of ZEB2.MicroRNA-30a 通过靶向调控 ZEB2 调节人鼻咽癌细胞的增殖、迁移、侵袭和凋亡。
Mol Med Rep. 2019 Aug;20(2):1672-1682. doi: 10.3892/mmr.2019.10387. Epub 2019 Jun 14.
9
miR-483-5p Targets MKNK1 to Suppress Wilms' Tumor Cell Proliferation and Apoptosis In Vitro and In Vivo.miR-483-5p 通过靶向调控 MKNK1 抑制肾母细胞瘤细胞的增殖和凋亡。
Med Sci Monit. 2019 Feb 24;25:1459-1468. doi: 10.12659/MSM.913005.
10
miR‑498 inhibits the growth and metastasis of liver cancer by targeting ZEB2.miR-498 通过靶向 ZEB2 抑制肝癌的生长和转移。
Oncol Rep. 2019 Mar;41(3):1638-1648. doi: 10.3892/or.2018.6948. Epub 2018 Dec 21.

本文引用的文献

1
BRAF-Activated Long Noncoding RNA Modulates Papillary Thyroid Carcinoma Cell Proliferation through Regulating Thyroid Stimulating Hormone Receptor.BRAF 激活的长链非编码 RNA 通过调节促甲状腺激素受体调节甲状腺癌细胞的增殖。
Cancer Res Treat. 2016 Apr;48(2):698-707. doi: 10.4143/crt.2015.118. Epub 2015 Aug 12.
2
MiR-99a Inhibits Cell Proliferation and Tumorigenesis through Targeting mTOR in Human Anaplastic Thyroid Cancer.微小RNA-99a通过靶向雷帕霉素靶蛋白抑制人间变性甲状腺癌的细胞增殖和肿瘤发生。
Asian Pac J Cancer Prev. 2015;16(12):4937-44. doi: 10.7314/apjcp.2015.16.12.4937.
3
MiR-9 and miR-21 as prognostic biomarkers for recurrence in papillary thyroid cancer.MiR-9和miR-21作为甲状腺乳头状癌复发的预后生物标志物。
Clin Exp Metastasis. 2015 Aug;32(6):521-30. doi: 10.1007/s10585-015-9724-3. Epub 2015 May 26.
4
MicroRNA-15a induces cell apoptosis and inhibits metastasis by targeting BCL2L2 in non-small cell lung cancer.微小RNA-15a通过靶向非小细胞肺癌中的BCL2L2诱导细胞凋亡并抑制转移。
Tumour Biol. 2015 Jun;36(6):4357-65. doi: 10.1007/s13277-015-3075-1. Epub 2015 Jan 22.
5
MiR-146b-5p promotes metastasis and induces epithelial-mesenchymal transition in thyroid cancer by targeting ZNRF3.微小RNA-146b-5p通过靶向锌指富含亮氨酸重复序列蛋白3促进甲状腺癌转移并诱导上皮-间质转化
Cell Physiol Biochem. 2015;35(1):71-82. doi: 10.1159/000369676. Epub 2015 Jan 2.
6
microRNA-335 inhibits proliferation, cell-cycle progression, colony formation, and invasion via targeting PAX6 in breast cancer cells.微小RNA-335通过靶向乳腺癌细胞中的PAX6抑制细胞增殖、细胞周期进程、集落形成和侵袭。
Mol Med Rep. 2015 Jan;11(1):379-85. doi: 10.3892/mmr.2014.2684. Epub 2014 Oct 16.
7
Down-regulation of miR-144 promotes thyroid cancer cell invasion by targeting ZEB1 and ZEB2.miR-144的下调通过靶向ZEB1和ZEB2促进甲状腺癌细胞侵袭。
Endocrine. 2015 Mar;48(2):566-74. doi: 10.1007/s12020-014-0326-7. Epub 2014 Jun 27.
8
MicroRNA-335 inhibits invasion and metastasis of colorectal cancer by targeting ZEB2.微小RNA-335通过靶向锌指E盒结合蛋白2抑制结直肠癌的侵袭和转移。
Med Oncol. 2014 Jun;31(6):982. doi: 10.1007/s12032-014-0982-8. Epub 2014 May 15.
9
miR-145 suppresses thyroid cancer growth and metastasis and targets AKT3.微小RNA-145抑制甲状腺癌的生长和转移,并以蛋白激酶B3为作用靶点。
Endocr Relat Cancer. 2014 Aug;21(4):517-31. doi: 10.1530/ERC-14-0077. Epub 2014 Apr 29.
10
The role of epithelial mesenchymal transition markers in thyroid carcinoma progression.上皮间质转化标志物在甲状腺癌进展中的作用。
Endocr Pathol. 2013 Dec;24(4):206-12. doi: 10.1007/s12022-013-9272-9.